What they do
Us2.ai offers an FDA-cleared software platform that automates the analysis of 2D echocardiograms. The software provides precise, automated measurements of cardiac structure and function in minutes, reducing variability and workflow strain for sonographers and cardiologists.
The record
- Vertical
- Cardiovascular
- Sub-segment
- Echocardiography AI
- Product type
- Software as a medical device
- Stage
- Series B
- Headquarters
- Singapore, Singapore
- Region
- Asia-Pacific
- Founded
- 2017
- Total funding
- $15M raised
Notable investors: Iraqi Ventures, Sequoia Capital India, Heal Partners, Tempus Partners.